MAC1/16

General Information


DRACP ID  DRACP00346

Peptide Name   MAC1/16

Sequence  GFGMALKLlKKVL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=32±2 µM MTT assay 48 h 1
SW480 Colon adenocarcinoma Carcinoma IC50> 100 µM MTT assay 48 h 1
CCRF-CEM Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia IC50=70 µM MTT assay 48 h 1

Hemolytic Activity  Human erythrocytes: IC50>200 μM

Normal (non-cancerous) Cytotoxicity  HUVEC: IC50=87±3 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  l=D-Leu

Chiral  Mix



Physicochemical Information


Formula  C62H107N15O12S

Absent amino acids  CDEHINPQRSTWY

Common amino acids  KL

Mass  150092

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  6

Net charge  3

Boman Index  1117

Hydrophobicity  73.85

Aliphatic Index  120

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22100226

Title  Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells

Doi 10.1016/j.peptides.2011.11.002

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.